Welcome to LookChem.com Sign In|Join Free
  • or
4-[4-(triflluoromethyl)phenyl]-7H-pyrrolo[2,3-d]pyrimidine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1595282-82-8

Post Buying Request

1595282-82-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1595282-82-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1595282-82-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,9,5,2,8 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1595282-82:
(9*1)+(8*5)+(7*9)+(6*5)+(5*2)+(4*8)+(3*2)+(2*8)+(1*2)=208
208 % 10 = 8
So 1595282-82-8 is a valid CAS Registry Number.

1595282-82-8Relevant academic research and scientific papers

Synthesis and biological evaluation of selected 7H-pyrrolo[2,3-d]pyrimidine derivatives as novel CDK9/CyclinT and Haspin inhibitors

Pieterse, Lianie,Beteck, Richard M.,Baratte, Blandine,Jesumoroti, Omobolanle J.,Robert, Thomas,Ruchaud, Sandrine,Bach, Stéphane,Legoabe, Lesetja J.

, (2021)

Protein kinases, including CDK9/CyclinT and Haspin, are regarded as potential drug targets in cancer therapy. Findings from a previous study suggested 7-azaindole as a privileged scaffold for producing inhibitors of CDK9/CyclinT and Haspin. Inspired by these findings, the current study synthesised and evaluated thirteen (13) C6-substituted 7-azaindole and twenty (20) C4-substituted structurally related 7H-pyrrolo[2,3-d]pyrimidine derivatives against a panel of protein kinases, including CDK9/CyclinT and Haspin. Eleven of the 7H-pyrrolo[2,3-d]pyrimidine derivatives exhibited activity toward CDK9/CyclinT, while 4 of compounds had activity against Haspin. The best CDK9/CyclinT (IC50 of 0.38 μM) and Haspin (IC50 of 0.11 μM) activities were achieved by compounds 7d and 7f, respectively. Hence, these compounds may be valuable starting points for development of new anti-cancer drugs.

Using 'biased-privileged' scaffolds to identify lysine methyltransferase inhibitors

Kashyap, Sudhir,Sandler, Joel,Peters, Ulf,Martinez, Eduardo J.,Kapoor, Tarun M.

supporting information, p. 2253 - 2260 (2014/04/17)

Methylation of histones by lysine methyltransferases (KMTases) plays important roles in regulating chromatin function. It is also now clear that improper KMTases activity is linked to human diseases, such as cancer. We report an approach that employs drug

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1595282-82-8